OR2M7
OR2M7 is a gene that encodes a protein in the olfactory receptor family. The olfactory receptor family is the largest in the genome. The family was discovered by Linda Buck and Richard Axel, who won the Nobel Prize in Physiology or Medicine in 2004 for their work. The olfactory receptors are G protein-coupled receptors (GPCRs) that detect odor molecules. The OR2M7 gene is one of the many olfactory receptor genes in the human genome.
Function[edit]
The OR2M7 gene encodes a protein that is a member of the olfactory receptor family. These receptors are located in the olfactory epithelium, which is a specialized tissue inside the nose that is involved in smell. The receptors are responsible for the detection of odor molecules, which are then translated into signals that are sent to the brain.
The OR2M7 protein is thought to have a role in the detection of specific odor molecules. However, the exact function of this protein is not yet fully understood. Research is ongoing to determine the specific role of this protein in the olfactory system.
Structure[edit]
The OR2M7 protein is a G protein-coupled receptor. These receptors have a specific structure that includes seven transmembrane domains. This structure allows the receptor to span the cell membrane and interact with odor molecules on one side and G proteins on the other side.
The interaction with G proteins triggers a cascade of events inside the cell that leads to the generation of a signal that is sent to the brain. This signal is interpreted by the brain as a specific smell.
Clinical significance[edit]
Mutations in the OR2M7 gene can potentially affect the function of the olfactory receptor and lead to a reduced ability to smell, a condition known as anosmia. However, more research is needed to fully understand the clinical significance of this gene.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
